SELLAS Life Sciences Group, Inc. (SLS)

7.735 +0.18 (+2.31%) USD  |  NASDAQ  |  May 22, 15:37
More

SELLAS Life Sciences Group Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Rezolute, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Spero Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Whitehawk Therapeutics, Inc. Upgrade